Published by GlobalApprove · updated 2026-10-09
- PF Atlas is free and requires no login, aggregating IPF treatments, clinical trials, drugs, mechanisms, and research in one searchable platform across English, Russian, and Hebrew
- ClinicalTrials.gov and PubMed are free alternatives but require checking multiple sites separately for trials, published research, and treatment information
- The Pulmonary Fibrosis Foundation offers free patient education and trial listings but focuses on caregiving resources rather than comprehensive drug pipelines or research mechanisms
- All major alternatives are free; the trade off is between specialized curation (PF Atlas) versus broader scope (ClinicalTrials.gov, PubMed) or patient focused education (PFF)
Understanding what PF Atlas actually offers
PF Atlas is a free, searchable research platform focused on idiopathic pulmonary fibrosis (IPF). According to its site, it aggregates IPF treatments, clinical trials, research papers, drug pipelines, and emerging therapies in one place. The platform operates in multiple languages (English, Russian, Hebrew) and requires no login to access basic content. It includes sections for treatments, clinical trials, drugs, mechanisms, and research methodology.
Direct alternatives for IPF research
If you are looking for similar resources, several established options exist. ClinicalTrials.gov, operated by the U.S. National Library of Medicine, is a free public registry where you can search active IPF trials by location, status, and sponsor. Unlike PF Atlas, it focuses exclusively on clinical trials rather than aggregating broader treatment and drug pipeline information. The search interface is detailed but less specialized to pulmonary fibrosis specifically.
PubMed, also maintained by the National Library of Medicine, provides free access to millions of peer reviewed biomedical research articles. You can search for IPF studies, but results are not curated or organized by treatment category or mechanism. This requires more manual filtering than a specialized atlas.
The Pulmonary Fibrosis Foundation (PFF) website offers educational resources, treatment guides, and clinical trial listings specifically for IPF patients and caregivers. This is a nonprofit resource focused on patient education rather than a comprehensive research database. It does not function as a searchable drug pipeline or mechanism catalog.
Comparison on key practical dimensions
PF Atlas differentiates itself by combining multiple data types (treatments, trials, drugs, mechanisms, and research) in a single searchable interface designed specifically for pulmonary fibrosis. Most alternatives require you to check multiple sites: one for trials, another for published research, and a third for treatment summaries.
Cost is identical across all these options: all are free. None charge subscription fees or require payment to access core content.
Language support is rare among alternatives. PF Atlas explicitly supports English, Russian, and Hebrew. ClinicalTrials.gov and PubMed offer English primarily, with limited multilingual support. The Pulmonary Fibrosis Foundation website is English only.
No login requirement on PF Atlas means you can access content immediately without creating an account or providing personal information. ClinicalTrials.gov and PubMed also operate without mandatory login, though creating an account allows you to save searches.
When each option makes sense
Choose ClinicalTrials.gov if your primary goal is finding active IPF clinical trials you might be eligible to join. Choose PubMed if you need access to published research papers and citations. Choose the Pulmonary Fibrosis Foundation if you want patient focused educational materials and support resources.
Use PF Atlas if you need a single interface to explore treatments, trials, drug pipelines, and research mechanisms together, particularly if you read in Russian or Hebrew or prefer not to create an account.
Important limitations to know
None of these resources replace consultation with a pulmonologist or respiratory specialist. Clinical trial eligibility depends on your specific diagnosis, disease stage, and medical history, which only a doctor can assess. Treatment recommendations must come from your healthcare provider, not from any database alone. These tools are for research and information gathering, not for medical decision making.
Frequently asked questions
What are good alternatives to PF Atlas
The main alternatives depend on your specific need. ClinicalTrials.gov is best for finding active IPF trials. PubMed provides access to published research papers. The Pulmonary Fibrosis Foundation offers patient education and trial listings. PF Atlas differs by combining treatments, trials, drugs, mechanisms, and research in one searchable interface with multilingual support (English, Russian, Hebrew) and no login required. All options are free.
How to get started with PF Atlas
Visit https://pf-atlas.com. No login or account creation is required. You can immediately search treatments, clinical trials, drugs, mechanisms, and research papers. The site offers a simple language option and supports English, Russian, and Hebrew. Use the search and filter functions to explore IPF related content.
Who is PF Atlas best for
PF Atlas suits researchers, healthcare providers, and patients who want to explore IPF treatments, clinical trials, drug pipelines, and research mechanisms in one place without creating an account. It is particularly useful for Russian and Hebrew speakers. It is not a substitute for medical advice from a doctor. Those seeking only clinical trial listings may find ClinicalTrials.gov more focused, and those wanting patient education may prefer the Pulmonary Fibrosis Foundation.
Disclosure: this article was published by GlobalApprove, part of the Astrarow Group, and features PF Atlas as its subject. It is a sponsored informational placement, not an independent review.